-logo-1200x675.png?v=20220915161652&w=240&h=240&zc=2){kind=logo}
Sarepta Therapeutics’ (SRPT) Sell Rating Reiterated at HC Wainwright
Sarepta Therapeutics (NASDAQ:SRPT – Get Free Report)‘s stock had its “sell” rating reiterated by stock analysts at HC Wainwright in a report issued on Thursday,Benzinga reports. They currently have a $75.00 target price on the biotechnology company’s stock. HC Wainwright’s price objective suggests a potential downside of 29.74% from the company’s previous close. Several other […]
Sarepta Therapeutics (NASDAQ:SRPT – Get Free Report)‘s stock had its “sell” rating reiterated by stock analysts at HC Wainwright in a report issued on Thursday,Benzinga reports. They currently have a $75.00 target price on the biotechnology company’s stock. HC Wainwright’s price objective suggests a potential downside of 29.74% from the company’s previous close. Several other […]
